Private · Company · Aksjeselskap
Zelluna Immunotherapy AS
816 823 862 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Oslo
↳ Brreg · companies
MoneyNOK
Revenue
kr 0
Operating result
−kr 101.8M
Net result
−kr 100.9M
Total assets
kr 89.3M
Equity
kr 79.3M
FY2025 kr 0 vs FY2024 kr 53k · -100% revenue
Regnskapsregisteret · company_financials · FY2025 (company)
Group financialsNOK
One filed year on record — the trend appears when a second year is published.
Regnskapsregisteret · company_revenue
Key figuresBrønnøysund
FY23FY24FY25TREND
Revenue0M0M0M
Operating result-106M-110M-102M
Net result-99M-105M-101M
Regnskapsregisteret · company_revenue
From the FY2025 accounts
FILEDAccounts filed for FY2025.
AUDITAudited by ERNST & YOUNG AS.
BALANCEEquity kr 79.3M.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose